Top-News

Co-Diagnostics Aktie News

Aktie
WKN:  A2DU6V ISIN:  US1897631057 US-Symbol:  CODX Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
0,3745 $
-0,012 $
-3,10%
0,32163 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
17,41 Mio. €
Streubesitz
83,28%
KGV
-0,66
Index-Zuordnung
-

Co-Diagnostics News

20.11.25 - PR Newswire
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
Co-​Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health PR Newswire
18.11.25 - PR Newswire
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA
Co-​Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-​of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA PR Newswire
13.11.25 - PR Newswire
Co-Diagnostics Reports Third Quarter 2025 Financial Results
Co-​Diagnostics Reports Third Quarter 2025 Financial Results PR Newswire
12.11.25 - PR Newswire
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
Utah Governor Cox and BioUtah Recognize Co-​Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia PR Newswire
05.11.25 - PR Newswire
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
Co-​Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd PR Newswire
03.11.25 - PR Newswire
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
Co-​Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform PR Newswire
31.10.25 - PR Newswire
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
Co-​Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast PR Newswire
30.10.25 - PR Newswire
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
Co-​Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia PR Newswire
29.10.25 - PR Newswire
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Co-​Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-​The-Market Under Nasdaq Rules PR Newswire
28.10.25 - PR Newswire
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Co-​Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-​The-Market Under Nasdaq Rules PR Newswire
27.10.25 - PR Newswire
Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East
Co-​Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle ...
22.10.25 - PR Newswire
Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia
Co-​Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia PR Newswire
16.10.25 - PR Newswire
Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing
Co-​Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing PR Newswire
13.10.25 - PR Newswire
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
Co-​Diagnostics, Inc. to Attend 2025 Maxim Growth Summit PR Newswire
30.09.25 - PR Newswire
Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
Co-​Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30 PR Newswire
18.09.25 - PR Newswire
Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Co-​Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-​The-Market Under Nasdaq Rules PR Newswire
17.09.25 - PR Newswire
Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Co-​Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-​The-Market Under Nasdaq Rules PR Newswire
16.09.25 - PR Newswire
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
Co-​Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East PR Newswire
11.09.25 - PR Newswire
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
Co-​Diagnostics, Inc. Performs Analysis of Chikungunya Co-​Primers® to Confirm Reactivity Against Known Virus Strains PR Newswire
09.09.25 - PR Newswire
Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit
Co-​Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit PR Newswire

Newssuche

Videos

newspaper
18:20 Uhr
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »